Related Experiment Videos
Pediatric mastocytosis
1Department of Dermatology, University of Cologne, Germany.
Insights
Pediatric mastocytosis, often transient, differs from adult forms. Genetic findings reveal distinct c-kit mutations in children versus adults, impacting mast cell growth factor receptor pathways.
Area of Science:
- Pediatric Hematology
- Dermatology
- Human Genetics
Background:
- Pediatric mastocytosis involves diverse skin lesions and symptoms due to elevated mast cells.
- Unlike adults, pediatric mastocytosis typically follows a transient clinical course.
- This suggests potential differences in the underlying pathogenetic mechanisms between pediatric and adult mastocytosis.
Purpose of the Study:
- To investigate the distinct pathogenetic mechanisms of pediatric mastocytosis compared to adult forms.
- To explore the role of genetic mutations, particularly in the c-kit gene, in disease development.
Main Methods:
- Analysis of genetic findings in pediatric and adult mastocytosis patients.
- Comparison of c-kit gene mutation status between different age groups.
- Clinical observation of disease course and symptom presentation.
Main Results:
- Adult mastocytosis commonly features activating mutations in the c-kit growth factor receptor.
- Most pediatric cases lack these activating mutations; some exhibit inactivating c-kit mutations.
- Activating c-kit mutations are primarily observed in children with progressive mastocytosis.
Conclusions:
- Genetic differences, specifically in c-kit mutations, underpin distinct pathogenetic mechanisms in pediatric and adult mastocytosis.
- Current management focuses on symptomatic relief with antihistamines and trigger avoidance.
- Further research into causal treatments for mastocytosis is warranted.
Abstract:
Pediatric mastocytosis presents with heterogeneous cutaneous lesions and symptoms that are caused by increased numbers of tissue mast cells. In contrast with adult patients with mastocytosis, the course of pediatric patients is usually transient. Therefore, it has long been speculated that pediatric and adult mastocytosis may be based on different pathogenetic mechanisms. Indeed, new genetic findings now indicate differences in the pathogenesis. Adult patients usually express activating mutations of the growth factor receptor c-kit. Most children lack these mutations but sometimes carry other inactivating mutations of c-kit. Only children with progressive mastocytosis seem to express the activating mutations seen in adults. Causal treatment is not yet available, but H1 and H2 antihistamines may provide relief of symptoms. It is important to counsel patients and their parents carefully to avoid triggers that induce systemic mast cell degranulation.